Identifying individuals at high risk of melanoma: A practical predictor of absolute risk

被引:86
作者
Fears, Thomas R.
Guerry, DuPont
Pfeiffer, Ruth M.
Sagebiel, Richard W.
Elder, David E.
Halpern, Allan
Holly, Elizabeth A.
Hartge, Patricia
Tucker, Margaret A.
机构
[1] NCI, Div Canc Epidemioil & Genet, NIH, Bethesda, MD 20892 USA
[2] Univ Penn, Sch Med, Melanoma Program, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[3] Univ Calif San Francisco, Melanoma Clin, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[5] Mem Sloan Kettering Canc Ctr, Serv Dermatol, New York, NY 10021 USA
关键词
D O I
10.1200/JCO.2005.04.1277
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose We developed a model to estimate the 5-year absolute risk of melanoma to efficiently identify individuals at increased risk of melanoma for potential interventions. Patients and Methods We used data from a case-control study with 718 non-Hispanic white patients with invasive cutaneous melanoma from melanoma clinics in Philadelphia, PA and San Francisco, CA; matched controls were 945 patients from outpatient clinics with similar catchment areas. All participants underwent extensive interviews and skin examinations. We selected easily obtained clinical characteristics and responses to simple questions for study in order to develop sex-specific relative risk models. These models were combined with incidence and mortality rates by United States geographic areas to develop estimates of the absolute risk of developing melanoma within 5 years. Results Relative risk models yielded an attributable risk of 86% for men and 89% for women, using at most seven variables. Attributable risks did not vary by age, ultraviolet B flux or hours outdoors. The absolute individual risks varied widely, depending on age, other host characteristics, and geographic area. Individual absolute risk can be estimated using a program available online. Conclusion Our procedures allow for estimating the absolute risk of developing melanoma to assist in the identification of patients at high risk. Such high-risk individuals could undergo interventions including a complete skin examination, counseling to avoid sun exposures, regular self and professional surveillance, or participation in prevention trials. It is important to emphasize that these projections are not intended to identify current melanoma cases.
引用
收藏
页码:3590 / 3596
页数:7
相关论文
共 24 条
[1]   Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma [J].
Balch, CM ;
Buzaid, AC ;
Soong, SJ ;
Atkins, MB ;
Cascinelli, N ;
Coit, DG ;
Fleming, ID ;
Gershenwald, JE ;
Houghton, A ;
Kirkwood, JM ;
McMasters, KM ;
Mihm, MF ;
Morton, DL ;
Reintgen, DS ;
Ross, MI ;
Sober, A ;
Thompson, JA ;
Thompson, JF .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3635-3648
[2]   ESTIMATING THE POPULATION ATTRIBUTABLE RISK FOR MULTIPLE RISK-FACTORS USING CASE-CONTROL DATA [J].
BRUZZI, P ;
GREEN, SB ;
BYAR, DP ;
BRINTON, LA ;
SCHAIRER, C .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1985, 122 (05) :904-913
[3]   Risk factors and individual probabilities of melanoma for whites [J].
Cho, E ;
Rosner, BA ;
Feskanich, D ;
Colditz, GA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) :2669-2675
[4]   Cutaneous melanoma: pathogenesis and rationale for chemoprevention [J].
Demierre, MF ;
Sondak, VK .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 53 (03) :225-239
[5]   Is routine screening for melanoma a benign practice? [J].
Edman, RL ;
Klaus, SN .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (07) :883-886
[6]  
Fears TR, 2002, CANCER RES, V62, P3992
[7]   PROJECTING INDIVIDUALIZED PROBABILITIES OF DEVELOPING BREAST-CANCER FOR WHITE FEMALES WHO ARE BEING EXAMINED ANNUALLY [J].
GAIL, MH ;
BRINTON, LA ;
BYAR, DP ;
CORLE, DK ;
GREEN, SB ;
SCHAIRER, C ;
MULVIHILL, JJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (24) :1879-1886
[8]   Screening for melanoma [J].
Geller, AC .
DERMATOLOGIC CLINICS, 2002, 20 (04) :629-+
[9]   Thin primary cutaneous malignant melanoma: A prognostic tree for 10-year metastasis is more accurate than American joint committee on cancer staging [J].
Gimotty, PA ;
Guerry, DP ;
Ming, ME ;
Elenitsas, R ;
Xu, XW ;
Czerniecki, B ;
Spitz, F ;
Schuchter, L ;
Elder, D .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (18) :3668-3676
[10]  
Girgis A, 1996, J Med Screen, V3, P47